DSM announces management changes
Royal DSM, the global Life Sciences and Materials Sciences company, today announces the following:
Jos Op Heij, currently Vice President Corporate Treasury, will take on the role of Senior Vice President Corporate Control and Accounting as of 1 August 2012, succeeding Loek Radix. Jos joined DSM in 1985 and holds a chartered controller degree. After positions in ICT, project management, demand chain management and a broad range of positions in finance and control, in 2005 Jos took on the responsibility for Treasury worldwide.
Hans Vossen, Vice President Investor Relations, will succeed Jos Op Heij as VP Corporate Treasury as of 1 August 2012. Hans started his career in EDP auditing at KPMG and joined DSM in 1991 as controller. After holding several positions in finance control and strategy, he joined Investor Relations in 2008.
Dave Huizing will succeed Hans Vossen as VP Investor Relations as of 1 July 2012. Dave started his career in DSM in 1985 as a lawyer. He held positions in Marketing & Sales and Key Account Management for DSM Materials businesses, before moving into general management positions, latterly at the Value Assurance Review team.
Loek Radix, Senior Vice President Corporate Control & Accounting, will stay in his current role until the completion of the Q2 results. He joined DSM in 1988 and, after having held several positions in the business, in 1999 became the Corporate Controller of DSM. A further announcement regarding his next steps will be made in the second half of 2012.
DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 22,000 employees deliver annual net sales of around €9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.
For more information:
|DSM Corporate Communications Herman Betten
tel. +31 (0) 45 5782421
|DSM Investor Relations Hans Vossen
tel. +31 (0) 45 5782864
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: DSM N.V. via Thomson Reuters ONE HUG#1607612